BMRN - Biomarin Pharmaceutical Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

17.21B

Cash

1.152B

Avg Qtr Burn

N/A

Short % of Float

3.75%

Insider Ownership

0.48%

Institutional Own.

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ROCTAVIAN (Valoctocogene roxaparvovec) Details Hemophilia	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VOXZOGO Details Genetic Short Stature Conditions	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.